• LABline
  • Magazine Archive
  • Webinars
  • Whitepapers
  • eBooks
  • Videos
  • Subscribe
    • ID 323032177 © Leo Rohmann | Dreamstime.com
    dreamstime_xxl_323032177
    ID 360501051 © Prostockstudio | Dreamstime.com
    dreamstime_xxl_360501051
    ID 339643448 © Yuri Arcurs | Dreamstime.com
    dreamstime_xxl_339643448
    ID 239686664 © Chernetskaya | Dreamstime.com
    dreamstime_xxl_239686664
    curveimage
    Courtesy of Caris Life Sciences
    PIQRAY® is a registered trademark of Novartis AG. VECTIBIX® is a registered trademark of Immunex Corporation. BRAFTOVI® is a registered trademark of Array BioPharma Inc. in the United States and various other countries. ERBITUX® is a registered trademark of ImClone LLC, a wholly owned subsidiary of Eli Lilly and Company. MEKINIST® is a registered trademark of Novartis AG Corporation Switzerland. KEYTRUDA® is a registered trademark of Merck. LENVIMA® (lenvatinib) is a registered trademark used by Eisai Inc. under license from Eisai R&D Management Co., Ltd.
    Assays

    Caris Life Sciences receives FDA approval for MI Cancer Seek as a companion diagnostic (CDx) test

    LABline
    Nov. 8, 2024
    MI Cancer Seek is the first and only simultaneous whole exome and whole transcriptome-based assay with CDx indications for adults and pediatric patients.
    Courtesy of Yourgene Health
    yourgene_cystic_fibrosis_base_assay_ivdr
    Assays

    Yourgene Health Cystic Fibrosis Base assay receives IVDR accreditation

    LABline
    Oct. 18, 2024
    Offers clinicians and patients additional confidence in quality and accuracy of test for cystic fibrosis diagnosis.
    sekisui_header
    Video

    Accessible and Accurate Testing Solutions from Home to Lab by Sekisui Diagnostics

    Sept. 20, 2024
    Accessible and Accurate Testing Solutions from Home to Lab by Sekisui Diagnostics.Sponsored by:
    ID 314050690 © Svetlana Diacenco | Dreamstime.com
    dreamstime_xxl_314050690
    Assays

    QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform

    LABline
    Sept. 19, 2024
    QIAGEN adds over 100 new validated QIAcuity digital PCR assays for cancer research, inherited genetic disorders, infectious disease surveillance, and other applications.
    hero_0924
    Video

    CLSI’s Focused on Preparing Labs for Change

    Sept. 11, 2024
    Clinical and Laboratory Standards Institute (CLSI) CEO Barb Jones shares how the global nonprofit’s standards, training and educational offerings prepare labs to meet the...
    Courtesy of QuidelOrtho
    7600_front_transparent
    ADLM 2024: DIASORIN
    Video

    Flexible Syndromic Solutions for Respiratory Diagnostics 

    Aug. 30, 2024
    Michelle Tabb and Giulia Amicarelli of Diasorin discuss the current challenges for respiratory testing and how customizable syndromic testing is contributing to diagnostic stewardship...
    Courtesy of Bio-Rad
    spiaplusproductimage2
    Assays

    Bio-Rad launches new Specialty Immunoassay Plus controls

    LABline
    Aug. 23, 2024
    Next generation of independent specialty IA quality controls features procalcitonin in liquid format.
    Photo 323621432 © Aumporn Charicha | Dreamstime.com
    Assays

    Diasorin receives FDA de-Novo grant for the Simplexa C. auris Direct assay on the LIAISON MDX instrument

    LABline
    July 19, 2024
    Simplexa C. auris Direct is a is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument for the direct in vitro qualitative detection of Candida auris DNA...

    Assays

    By Africa Studio on Adobe Stock
    Photo 47559398 © Mark Adams | Dreamstime.com
    Courtesy of OGT
    Courtesy of Roche
    Photo 232587123 © Lacheev | Dreamstime.com
    Photo 34206315 © Wong Yu Liang | Dreamstime.com
    Photo 195801581 © Yuriy Mingirov | Dreamstime.com